查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
白色生物技术市场 - 全球及区域分析：按应用、产品和国家 - 分析与预测（2025 年至 2034 年）
市场调查报告书
商品编码
1757393

白色生物技术市场 - 全球及区域分析：按应用、产品和国家 - 分析与预测（2025 年至 2034 年）

White Biotechnology Market - A Global and Regional Analysis: Focus on Application, Product, and Country Analysis - Analysis and Forecast, 2025-2034
出版日期: | 出版商: BIS Research | 英文 120 Pages | 商品交期: 1-5个工作天内

价格

白色生物技术，也称为工业生物技术，利用活细胞、酵素和发酵过程生产生物基化学品、材料和能源载体。

主要应用领域包括生质燃料（例如先进生物柴油和生质乙醇）、生物化学（有机酸、溶剂）、工业酶（用于清洁剂、纺织品和食品加工）、生物材料（生物聚合物、生质塑胶）以及生物修復和可再生原料增值等新兴领域。合成生物学、代谢工程和蛋白质工程的技术进步使得更有效率的菌株开发、更高的产量和更低的製程成本成为可能。同时，用于生物製程优化的机器学习、高通量筛检和可扩展的连续流发酵等数位工具正在加快新生物产品的上市时间。生物学数位化的融合正在推动白色生物技术市场从小众专业应用向大规模工业用途的转变。

白色生物技术市场生命週期阶段

主要市场统计数据
预测期 2025-2034
2025年评估 3375.6亿美元
2034年的预测 6729.2亿美元
复合年增长率 7.97%

白色生物技术市场正处于成长阶段，其特点是研发投入强劲、技术商业化快速推进，以及老牌化工企业和敏捷的生物技术新兴企业群体的不断壮大。创新分散在各个细分领域，从诺维信和杜邦等酵素製造商到生物基材料领域的先驱企业，市场集中度仍然较低，为新进业者留下了充足的发展空间。随着生产流程效率的提升以及生物基产品法律规范的日趋成熟，未来十年，该行业很可能走向整合和成熟，重大战略联盟和併购将塑造竞争格​​局。

白色生物技术市场细分

细分一：按应用

  • 生质能源
  • 食品/饲料添加剂
  • 医药原料
  • 个人护理和家居产品
  • 其他的

生质能源是全球白色生物技术市场突出的应用领域之一。

细分2：依产品类型

  • 生物化学
  • 生质燃料
  • 生物材料
  • 生物製品

根据产品类型，全球白色生物技术市场估计由生物化学领域主导。

细分3：按地区

  • 北美—美国、加拿大、墨西哥
  • 欧洲——德国、法国、义大利、西班牙、英国等。
  • 亚太地区－中国、日本、韩国、印度及世界其他地区
  • 其他——南美洲、中东和非洲

在白色生物技术市场中，由于对可再生资源的需求不断增长以及政府的倡议，北美预计将在生产方面获得推动力。

需求——驱动因素与限制因素

以下是推动全球白色生物技术市场需求的因素：

  • 对可再生资源的需求不断增加

由于以下挑战，全球白色生物技术市场预计还将面临一些限制：

  • 初期投资成本高

白色生物技术市场：主要企业与竞争格局

白色生物技术市场的竞争格局呈现多元化特征，由老牌化学和生命科学公司以及一波专注于生物技术的创新企业主导。诺维信公​​司、杜邦公司、BASF公司和赢创工业股份公司等主要企业正利用其强大的研发能力和全球生产网络，大规模供应工业酵素、生物基聚合物和特种生物化学品。同时，Amyris公司、Genomatica公司、Codexis公司和Ginkgo Bioworks等敏捷的纯生物技术公司正凭藉先进的代谢工程、专有菌株开发平台和数位化生物製程优化工具，在加快产品上市速度和降低单位成本方面脱颖而出。阿彻丹尼尔斯米德兰公司、嘉吉公司、科比昂公司和龙沙集团等中型市场公司正在原料整合和循环经济解决方案方面展开竞争，而充满活力的併购环境以及将化工巨头与生物技术企业联繫起来的战略伙伴关係继续重塑市场占有率、推动整合并促进下一代技术转移。

本报告研究了全球白色生物技术市场，并概述了市场、应用、产品和国家趋势以及参与市场的公司概况。

目录

执行摘要

第一章市场：产业展望

  • 趋势：现况与未来影响评估
  • 相关利益者分析
    • 使用案例
    • 最终用户和购买标准
  • 市场动态概览
    • 市场驱动因素
    • 市场限制
    • 市场机会
  • 投资状况及研发趋势
  • 未来展望与市场蓝图

第二章 白色生物技术市场（依应用）

  • 应用程式细分
  • 使用摘要
  • 白色生物技术市场（按应用）
    • 生质能源
    • 食品/饲料添加剂
    • 医药原料
    • 个人保健产品和家居产品
    • 其他的

第三章 白色生物技术市场（依产品）

  • 产品细分
  • 产品摘要
  • 白色生物技术市场（按产品类型）
    • 生物化学
    • 生质燃料
    • 生物材料
    • 生物製品

第四章 白色生物技术市场（按地区）

  • 白色生物技术市场（按地区）
  • 北美洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 主要企业
    • 目的
    • 产品
    • 北美（按国家/地区）
  • 欧洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 主要企业
    • 目的
    • 产品
    • 欧洲（按国家/地区）
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 主要企业
    • 目的
    • 产品
    • 亚太地区（按国家/地区）
  • 其他地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 主要企业
    • 目的
    • 产品
    • 其他地区（按地区）

第五章 市场竞争基准化分析与公司概况

  • 未来展望
  • 地理评估
  • 公司简介
    • Medtronic
    • Novozymes
    • BASF SE
    • DuPont
    • Cargill, Inc.
    • Royal DSM NV
    • Archer Daniles Midland Company
    • BioAmber Inc.
    • Lesaffre
    • Corbion NV
    • Evonik Industries AG
    • Genomatica, Inc
    • Ginkgo Bioworks
    • Amyris Inc.
    • TerraVia Holdings, Inc
  • 其他主要企业

第六章调查方法

Product Code: MC02960SA

Global White Biotechnology Market: Industry Overview

White biotechnology also known as industrial biotechnology leverages living cells, enzymes and fermentation processes to produce bio-based chemicals, materials and energy carriers. Core application areas include biofuels (e.g., advanced biodiesel and bioethanol), biochemicals (organic acids, solvents), industrial enzymes (for detergents, textiles, food processing), biomaterials (biopolymers, bioplastics) and emerging fields such as bioremediation and renewable feedstock valorization. Technological advances in synthetic biology, metabolic engineering and protein engineering are enabling more efficient strain development, higher yields and reduced process costs. Concurrently, digital tools-machine learning for bioprocess optimization, high-throughput screening and scalable continuous-flow fermentation-are accelerating time-to-market for new bioproducts. This convergence of biology and digitalization is driving white biotechnology market's transformation from niche specialty applications toward large-scale industrial adoption.

White Biotechnology Market Lifecycle Stage

KEY MARKET STATISTICS
Forecast Period2025 - 2034
2025 Evaluation$337.56 Billion
2034 Forecast$672.92 Billion
CAGR7.97%

The white biotechnology market is firmly in its growth phase, characterized by robust R&D investment, rapid technology commercialization and an expanding base of both established chemical-industry incumbents and agile biotech startups. Market concentration remains moderate, with innovation dispersed across diverse segments-from enzyme producers like Novozymes and DuPont to bio-based materials pioneers-indicating ample room for new entrants. As process efficiencies improve and regulatory frameworks for bio-based products mature, the industry is poised to transition toward consolidation and maturation over the next decade, with large strategic partnerships and mergers likely to shape the competitive landscape.

White Biotechnology Market Segmentation:

Segmentation 1: by Application

  • Bioenergy
  • Food and Feed Additives
  • Pharmaceutical Ingredients
  • Personal Care and Household Products
  • Others

Bioenergy is one of the prominent application segments in the global white biotechnology market.

Segmentation 2: by Product Type

  • Biochemical
  • Biofuel
  • Biomaterial
  • Bioproduct

The global white biotechnology market is estimated to be led by the biochemical segment in terms of product type.

Segmentation 3: by Region

  • North America - U.S., Canada, and Mexico
  • Europe - Germany, France, Italy, Spain, U.K., and Rest-of-Europe
  • Asia-Pacific - China, Japan, South Korea, India, and Rest-of-Asia-Pacific
  • Rest-of-the-World - South America and Middle East and Africa

In the white biotechnology market, North America is anticipated to gain traction in terms of production, with increasing demand towards renewable resources and govement initiatives.

Demand - Drivers and Limitations

The following are the demand drivers for the global white biotechnology market:

  • Increasing Demand Towards Renewable Resources

The global white biotechnology market is expected to face some limitations as well due to the following challenges:

  • High Initial Investment Costs

White Biotechnology Market Key Players and Competition Synopsis

The white biotechnology market sector is characterized by a diverse competitive landscape dominated by established chemical and life-sciences firms alongside a wave of specialized biotech innovators. Leading companies-such as Novozymes A/S, DuPont de Nemours, BASF SE, Evonik Industries AG-leverage extensive R&D capabilities and global production networks to supply industrial enzymes, bio-based polymers and specialty biochemicals at scale. At the same time, agile pure-play biotechnology companies-Amyris Inc., Genomatica Inc., Codexis Inc. and Ginkgo Bioworks-are differentiating themselves through advanced metabolic engineering, proprietary strain-development platforms and digital bioprocess optimization tools that accelerate time-to-market and reduce unit costs. Mid-tier players including Archer Daniels Midland, Cargill Incorporated, Corbion N.V. and Lonza Group Ltd. compete on feedstock integration and circular-economy solutions, while an active M&A environment and strategic partnerships-linking chemical giants with biotech startups-continue to reshape market share, drive consolidation and foster next-generation technology transfer.

Some prominent names established in the white biotechnology market are:

  • Medtronic
  • Novozymes
  • BASF SE
  • DuPont
  • Cargill, Inc.
  • Royal DSM N.V.
  • Archer Daniles Midland Company
  • BioAmber Inc.
  • Lesaffre
  • Corbion N.V.
  • Evonik Industries AG
  • Genomatica, Inc
  • Ginkgo Bioworks
  • Amyris Inc.
  • TerraVia Holdings, Inc

Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1. Markets: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
  • 1.2 Stakeholder Analysis
    • 1.2.1 Use Case
    • 1.2.2 End User and Buying Criteria
  • 1.3 Market Dynamics Overview
    • 1.3.1 Market Drivers
    • 1.3.2 Market Restraints
    • 1.3.3 Market Opportunities
  • 1.4 Investment Landscape and R&D Trends
  • 1.5 Future Outlook and Market Roadmap

2. White Biotechnology Market (by Application)

  • 2.1 Application Segmentation
  • 2.2 Application Summary
  • 2.3 White Biotechnology Market (by Application)
    • 2.3.1 Bioenergy
    • 2.3.2 Food and Feed Additives
    • 2.3.3 Pharmaceutical Ingredients
    • 2.3.4 Personal Care and Household Products
    • 2.3.5 Others

3. White Biotechnology Market (by Product)

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 White Biotechnology Market (by Product Type)
    • 3.3.1 Biochemical
    • 3.3.2 Biofuel
    • 3.3.3 Biomaterial
    • 3.3.4 Bioproduct

4. White Biotechnology Market (by Region)

  • 4.1 White Biotechnology Market (by Region)
  • 4.2 North America
    • 4.2.1 Regional Overview
    • 4.2.2 Driving Factors for Market Growth
    • 4.2.3 Factors Challenging the Market
    • 4.2.4 Key Companies
    • 4.2.5 Application
    • 4.2.6 Product
    • 4.2.7 North America (by Country)
      • 4.2.7.1 U.S.
        • 4.2.7.1.1 Market by Application
        • 4.2.7.1.2 Market by Product
      • 4.2.7.2 Canada
        • 4.2.7.2.1 Market by Application
        • 4.2.7.2.2 Market by Product
  • 4.3 Europe
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Key Companies
    • 4.3.5 Application
    • 4.3.6 Product
    • 4.3.7 Europe (by Country)
      • 4.3.7.1 Germany
        • 4.3.7.1.1 Market by Application
        • 4.3.7.1.2 Market by Product
      • 4.3.7.2 France
        • 4.3.7.2.1 Market by Application
        • 4.3.7.2.2 Market by Product
      • 4.3.7.3 Italy
        • 4.3.7.3.1 Market by Application
        • 4.3.7.3.2 Market by Product
      • 4.3.7.4 Spain
        • 4.3.7.4.1 Market by Application
        • 4.3.7.4.2 Market by Product
      • 4.3.7.5 U.K.
        • 4.3.7.5.1 Market by Application
        • 4.3.7.5.2 Market by Product
      • 4.3.7.6 Rest-of-Europe
        • 4.3.7.6.1 Market by Application
        • 4.3.7.6.2 Market by Product
  • 4.4 Asia-Pacific
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Key Companies
    • 4.4.5 Application
    • 4.4.6 Product
    • 4.4.7 Asia-Pacific (by Country)
      • 4.4.7.1 China
        • 4.4.7.1.1 Market by Application
        • 4.4.7.1.2 Market by Product
      • 4.4.7.2 Japan
        • 4.4.7.2.1 Market by Application
        • 4.4.7.2.2 Market by Product
      • 4.4.7.3 India
        • 4.4.7.3.1 Market by Application
        • 4.4.7.3.2 Market by Product
      • 4.4.7.4 South Korea
        • 4.4.7.4.1 Market by Application
        • 4.4.7.4.2 Market by Product
      • 4.4.7.5 Rest-of-Asia-Pacific
        • 4.4.7.5.1 Market by Application
        • 4.4.7.5.2 Market by Product
  • 4.5 Rest-of-the-World
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 Key Companies
    • 4.5.5 Application
    • 4.5.6 Product
    • 4.5.7 Rest-of-the-World (by Region)
      • 4.5.7.1 South America
        • 4.5.7.1.1 Market by Application
        • 4.5.7.1.2 Market by Product
      • 4.5.7.2 Middle East and Africa
        • 4.5.7.2.1 Market by Application
        • 4.5.7.2.2 Market by Product

5. Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Next Frontiers
  • 5.2 Geographic Assessment
  • 5.3 Company Profiles
    • 5.3.1 Medtronic
      • 5.3.1.1 Overview
      • 5.3.1.2 Top Products/Product Portfolio
      • 5.3.1.3 Top Competitors
      • 5.3.1.4 Target Customers
      • 5.3.1.5 Key Personnel
      • 5.3.1.6 Analyst View
      • 5.3.1.7 Market Share
    • 5.3.2 Novozymes
      • 5.3.2.1 Overview
      • 5.3.2.2 Top Products/Product Portfolio
      • 5.3.2.3 Top Competitors
      • 5.3.2.4 Target Customers
      • 5.3.2.5 Key Personnel
      • 5.3.2.6 Analyst View
      • 5.3.2.7 Market Share
    • 5.3.3 BASF SE
      • 5.3.3.1 Overview
      • 5.3.3.2 Top Products/Product Portfolio
      • 5.3.3.3 Top Competitors
      • 5.3.3.4 Target Customers
      • 5.3.3.5 Key Personnel
      • 5.3.3.6 Analyst View
      • 5.3.3.7 Market Share
    • 5.3.4 DuPont
      • 5.3.4.1 Overview
      • 5.3.4.2 Top Products/Product Portfolio
      • 5.3.4.3 Top Competitors
      • 5.3.4.4 Target Customers
      • 5.3.4.5 Key Personnel
      • 5.3.4.6 Analyst View
      • 5.3.4.7 Market Share
    • 5.3.5 Cargill, Inc.
      • 5.3.5.1 Overview
      • 5.3.5.2 Top Products/Product Portfolio
      • 5.3.5.3 Top Competitors
      • 5.3.5.4 Target Customers
      • 5.3.5.5 Key Personnel
      • 5.3.5.6 Analyst View
      • 5.3.5.7 Market Share
    • 5.3.6 Royal DSM N.V.
      • 5.3.6.1 Overview
      • 5.3.6.2 Top Products/Product Portfolio
      • 5.3.6.3 Top Competitors
      • 5.3.6.4 Target Customers
      • 5.3.6.5 Key Personnel
      • 5.3.6.6 Analyst View
      • 5.3.6.7 Market Share
    • 5.3.7 Archer Daniles Midland Company
      • 5.3.7.1 Overview
      • 5.3.7.2 Top Products/Product Portfolio
      • 5.3.7.3 Top Competitors
      • 5.3.7.4 Target Customers
      • 5.3.7.5 Key Personnel
      • 5.3.7.6 Analyst View
      • 5.3.7.7 Market Share
    • 5.3.8 BioAmber Inc.
      • 5.3.8.1 Overview
      • 5.3.8.2 Top Products/Product Portfolio
      • 5.3.8.3 Top Competitors
      • 5.3.8.4 Target Customers
      • 5.3.8.5 Key Personnel
      • 5.3.8.6 Analyst View
      • 5.3.8.7 Market Share
    • 5.3.9 Lesaffre
      • 5.3.9.1 Overview
      • 5.3.9.2 Top Products/Product Portfolio
      • 5.3.9.3 Top Competitors
      • 5.3.9.4 Target Customers
      • 5.3.9.5 Key Personnel
      • 5.3.9.6 Analyst View
      • 5.3.9.7 Market Share
    • 5.3.10 Corbion N.V.
      • 5.3.10.1 Overview
      • 5.3.10.2 Top Products/Product Portfolio
      • 5.3.10.3 Top Competitors
      • 5.3.10.4 Target Customers
      • 5.3.10.5 Key Personnel
      • 5.3.10.6 Analyst View
      • 5.3.10.7 Market Share
    • 5.3.11 Evonik Industries AG
      • 5.3.11.1 Overview
      • 5.3.11.2 Top Products/Product Portfolio
      • 5.3.11.3 Top Competitors
      • 5.3.11.4 Target Customers
      • 5.3.11.5 Key Personnel
      • 5.3.11.6 Analyst View
      • 5.3.11.7 Market Share
    • 5.3.12 Genomatica, Inc
      • 5.3.12.1 Overview
      • 5.3.12.2 Top Products/Product Portfolio
      • 5.3.12.3 Top Competitors
      • 5.3.12.4 Target Customers
      • 5.3.12.5 Key Personnel
      • 5.3.12.6 Analyst View
      • 5.3.12.7 Market Share
    • 5.3.13 Ginkgo Bioworks
      • 5.3.13.1 Overview
      • 5.3.13.2 Top Products/Product Portfolio
      • 5.3.13.3 Top Competitors
      • 5.3.13.4 Target Customers
      • 5.3.13.5 Key Personnel
      • 5.3.13.6 Analyst View
      • 5.3.13.7 Market Share
    • 5.3.14 Amyris Inc.
      • 5.3.14.1 Overview
      • 5.3.14.2 Top Products/Product Portfolio
      • 5.3.14.3 Top Competitors
      • 5.3.14.4 Target Customers
      • 5.3.14.5 Key Personnel
      • 5.3.14.6 Analyst View
      • 5.3.14.7 Market Share
    • 5.3.15 TerraVia Holdings, Inc
      • 5.3.15.1 Overview
      • 5.3.15.2 Top Products/Product Portfolio
      • 5.3.15.3 Top Competitors
      • 5.3.15.4 Target Customers
      • 5.3.15.5 Key Personnel
      • 5.3.15.6 Analyst View
      • 5.3.15.7 Market Share
  • 5.4 Other Key Companies

6. Research Methodology

List of Figures

  • Figure 1: White Biotechnology Market (by Scenario), $Billion, 2025, 2028, and 2034
  • Figure 2: White Biotechnology Market (by Region), $Billion, 2024, 2027, and 2034
  • Figure 3: White Biotechnology Market (by Application), $Billion, 2024, 2027, and 2034
  • Figure 4: White Biotechnology Market (by Product), $Billion, 2024, 2027, and 2034
  • Figure 5: Competitive Landscape Snapshot
  • Figure 6: Supply Chain Analysis
  • Figure 7: Value Chain Analysis
  • Figure 8: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 9: U.S. White Biotechnology Market, $Billion, 2024-2034
  • Figure 10: Canada White Biotechnology Market, $Billion, 2024-2034
  • Figure 11: Germany White Biotechnology Market, $Billion, 2024-2034
  • Figure 12: France White Biotechnology Market, $Billion, 2024-2034
  • Figure 13: Italy White Biotechnology Market, $Billion, 2024-2034
  • Figure 14: Spain White Biotechnology Market, $Billion, 2024-2034
  • Figure 15: U.K. White Biotechnology Market, $Billion, 2024-2034
  • Figure 16: Rest-of-Europe White Biotechnology Market, $Billion, 2024-2034
  • Figure 17: China White Biotechnology Market, $Billion, 2024-2034
  • Figure 18: Japan White Biotechnology Market, $Billion, 2024-2034
  • Figure 19: India White Biotechnology Market, $Billion, 2024-2034
  • Figure 20: South Korea White Biotechnology Market, $Billion, 2024-2034
  • Figure 21: Rest-of-Asia-Pacific White Biotechnology Market, $Billion, 2024-2034
  • Figure 22: South America White Biotechnology Market, $Billion, 2024-2034
  • Figure 23: Middle East and Africa White Biotechnology Market, $Billion, 2024-2034
  • Figure 24: Strategic Initiatives (by Company), 2021-2025
  • Figure 25: Share of Strategic Initiatives, 2021-2025
  • Figure 26: Data Triangulation
  • Figure 27: Top-Down and Bottom-Up Approach
  • Figure 28: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Region
  • Table 3: Trends Overview
  • Table 4: Application Summary (by Application)
  • Table 5: Product Summary (by Product)
  • Table 6: White Biotechnology Market (by Region), $Billion, 2024-2034
  • Table 7: North America White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 8: North America White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 9: U.S. White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 10: U.S. White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 11: Canada White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 12: Canada White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 13: Europe White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 14: Europe White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 15: Germany White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 16: Germany White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 17: France White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 18: France White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 19: Italy White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 20: Italy White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 21: Spain White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 22: Spain White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 23: U.K. White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 24: U.K. White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 25: Rest-of-Europe White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 26: Rest-of-Europe White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 27: Asia-Pacific White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 28: Asia-Pacific White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 29: China White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 30: China White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 31: Japan White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 32: Japan White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 33: India White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 34: India White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 35: South Korea White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 36: South Korea White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 37: Rest-of-Asia-Pacific White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 38: Rest-of-Asia-Pacific White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 39: Rest-of-the-World White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 40: Rest-of-the-World White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 41: South America White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 42: South America White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 43: Middle East and Africa White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 44: Middle East and Africa White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 45: Market Share